Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Development Targeting Severe and Persistent Negative Symptoms

NCT01550666 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT01550666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01550666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Development Targeting Severe and Persistent Negative Symptoms
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
January 31, 2015
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia